AB1040: Bill Text

AB1040,25 Section 25. 111.32 (9m) of the statutes is created to read:

AB1040,,131 111.32 (9m) “Lawful product” does not include a medical cannabis product.

AB1040,26 Section 26. 111.32 (12c) of the statutes is created to read:

AB1040,,133 111.32 (12c) “Medical cannabis product” has the meaning given in s. 94.57 (1) (f).

AB1040,27 Section 27. 111.34 (1) (b) of the statutes is amended to read:

AB1040,,135 111.34 (1) (b) Refusing Subject to sub. (3), refusing to reasonably accommodate an employee’s or prospective employee’s disability unless the employer can demonstrate that the accommodation would pose a hardship on the employer’s program, enterprise or business.

AB1040,28 Section 28. 111.34 (3) of the statutes is created to read:

AB1040,,137 111.34 (3) (a) Notwithstanding s. 111.322, this subchapter does not apply with respect to any act of an employer based upon an individual’s use of a medical cannabis product, the individual’s other use of cannabis, as defined in s. 94.57 (1) (a), or the individual testing positive for the presence of tetrahydrocannabinols.

AB1040,,138 (b) Nothing in this subchapter requires an employer to permit, accommodate, or allow the medical use of a medical cannabis product, or to modify any job or working conditions of any employee who engages in the medical use of medical cannabis products or who for any reason seeks to engage in the medical use of medical cannabis products.

AB1040,,139 (c) Nothing in this subchapter prohibits an employer from refusing to hire, terminating, discharging, disciplining, or otherwise discriminating against an individual with respect to hiring, discharging, tenure, promotion, or compensation, or in terms, conditions, or privileges of employment as a result, in whole or in part, of the individual’s medical use of a medical cannabis product, the individual’s other use of cannabis, as defined in s. 94.57 (1) (a), or the individual testing positive for the presence of tetrahydrocannabinols, regardless of any impairment or lack of impairment resulting therefrom.

AB1040,29 Section 29. 175.60 (2) (b) of the statutes is amended to read:

AB1040,,141 175.60 (2) (b) The department may not impose conditions, limitations, or requirements that are not expressly provided for in this section on the issuance, scope, effect, or content of a license. The department may not refuse to issue or renew a license, or may not suspend or revoke a license, solely because of an individual’s lawful use or possession of a medical cannabis product under s. 94.57 or ch. 259 or because the individual is a registered patient, as defined in s. 961.01 (20hm).

AB1040,30 Section 30. 224.30 (6) of the statutes is created to read:

AB1040,,143 224.30 (6) Providing financial services to lawful cannabis-related businesses. (a) In this subsection, “financial institution” has the meaning given in s. 943.80 (2).

AB1040,,144 (b) Neither the division nor the office of credit unions may take adverse action against a financial institution or person acting on behalf of or providing services to a financial institution solely on the basis that the financial institution or person receives deposits, extends credit, conducts funds transfers, transports cash or other financial instruments, or provides other financial services to a cannabis grower, processor, or laboratory licensed under s. 94.57 or a medical cannabis dispensary operating pursuant to s. 259.10.

AB1040,31 Section 31. 224.77 (1) (o) of the statutes is amended to read:

AB1040,,146 224.77 (1) (o) In the course of practice as a mortgage banker, mortgage loan originator, or mortgage broker, except in relation to housing designed to meet the needs of elderly individuals, treat a person unequally solely because of sex, race, color, handicap, sexual orientation, as defined in s. 111.32 (13m), religion, national origin, use of medical cannabis products, as defined in s. 94.57 (1) (f), age, or ancestry, the person’s lawful source of income, or the sex, marital status, or status as a victim of domestic abuse, sexual assault, or stalking, as defined in s. 106.50 (1m) (u), of the person maintaining a household.

AB1040,32 Section 32. 234.29 of the statutes is amended to read:

AB1040,,148 234.29 Equality of occupancy and employment. The authority shall require that occupancy of housing projects assisted under this chapter be open to all regardless of sex, race, use of medical cannabis products, as defined in s. 94.57 (1) (f), religion, sexual orientation, status as a victim of domestic abuse, sexual assault, or stalking, as defined in s. 106.50 (1m) (u), or creed, and that contractors and subcontractors engaged in the construction of economic development or housing projects, shall provide an equal opportunity for employment, without discrimination as to sex, race, religion, sexual orientation, or creed.

AB1040,33 Section 33. Chapter 259 of the statutes is created to read:

AB1040,,150 CHAPTER 259

AB1040,,151 MEDICAL CANNABIS

AB1040,,152 259.01 Definitions. In this chapter:

AB1040,,153 (1) “Cannabis” has the meaning given for “marijuana” in s. 961.01 (14).

AB1040,,154 (1m) “Department” means the department of health services.

AB1040,,155 (2) “Dispensary” means an entity operated by the office to purchase packaged and labeled medical cannabis products from a processor licensed under s. 94.57 (5) and to sell medical cannabis products to patients and caregivers who hold a valid registry identification card issued by the office.

AB1040,,156 (3) “Grower” has the meaning given in s. 94.57 (1) (b).

AB1040,,157 (4) “Laboratory” has the meaning given in s. 94.57 (1) (c).

AB1040,,158 (5) “Legal custody” has the meaning given in s. 767.001 (2).

AB1040,,159 (7) “Medical cannabis product” has the meaning given in s. 94.57 (1) (f).

AB1040,,160 (8) “Office” means the office of medical cannabis regulation.

AB1040,,161 (9) “Patient” means an individual who holds a valid registry identification card under s. 259.04 to use medical cannabis products.

AB1040,,162 (10) “Pharmacist” has the meaning given in s. 450.01 (15).

AB1040,,163 (11) “Prescriber” means all of the following:

AB1040,,164 (a) An advanced practice nurse prescriber certified under s. 441.16 (2).

AB1040,,165 (b) A physician licensed under s. 448.02.

AB1040,,166 (c) A physician assistant licensed under s. 448.974.

AB1040,,167 (12) “Processor” has the meaning given in s. 94.57 (1) (g).

AB1040,,168 (13) “Resident” means an individual who maintains his or her place of permanent abode in this state. Domiciliary intent is required to establish that a person is maintaining his or her place of permanent abode in this state. Mere ownership of property is not sufficient to establish domiciliary intent. Evidence of domiciliary intent includes the location where the individual votes, pays personal income taxes, or obtains a driver’s license.

AB1040,,169 (14) “Residential care facility” means all of the following:

AB1040,,170 (a) A nursing home, as defined in s. 50.01 (3).

AB1040,,171 (b) An adult family home, as defined in s. 50.01 (1).

AB1040,,172 (c) A community-based residential facility, as defined in s. 50.01 (1g).

AB1040,,173 (d) A residential care apartment complex, as defined in s. 50.01 (6d).

AB1040,,174 (e) A hospice, as defined in s. 50.90 (1).

AB1040,,175 (f) A facility, as defined in s. 647.01 (4).

AB1040,,176 (g) A swing bed in an acute care facility or extended care facility, as specified in 42 USC 1395tt.

AB1040,,177 (15) “Severe chronic pain” means pain that dominates the senses, that interferes with the essential activities for daily living, that has persisted for at least 3 months, and that is not responsive to or appropriate for other therapies.

AB1040,,178 259.02 Possession and sale prohibited. No person may possess, sell, transfer, or transport cannabis or medical cannabis products unless the person is licensed under s. 94.57, the person holds a valid registry identification card issued by the office under s. 259.04, or the person is an agent or employee of a dispensary operating pursuant to s. 259.10.

AB1040,,179 259.03 Office of medical cannabis regulation. (1) The office shall oversee and regulate the dispensing of medical cannabis products.

AB1040,,180 (2) The office shall promulgate rules establishing safety and security requirements for the premises of dispensaries that handle cannabis or medical cannabis products.

AB1040,,181 (3) Annually, no later than October 15, the office shall submit a report to the chief clerk of each house of the legislature for distribution to the legislature under s. 13.172 (2) on the performance of the medical cannabis program under this chapter. The report shall include information on all of the following:

AB1040,,182 (a) The number of patients included in the patient and caregiver registry under s. 259.04.

AB1040,,183 (b) The medical conditions that have qualified patients for inclusion in the patient and caregiver registry under s. 259.04 expressed as a total number and a percentage of all the patients included on the patient and caregiver registry.

AB1040,,184 (c) The number of doses and type of medical cannabis products dispensed.

AB1040,,185 (d) The residency by county of patients who possess a valid patient registry identification card under s. 259.04.

AB1040,,186 (e) The expenses and revenues of the program over the previous year, all funds held in reserve for the program, and an estimation of the expenses and revenues of the program over the following year.

AB1040,,187 (4) The office shall ensure that any information that is in the office’s possession and that could create a security risk if disclosed is confidential and not open to public inspection or copying under s. 19.35 (1), except that it shall be made available to a law enforcement agency or law enforcement officer.

AB1040,,188 259.04 Patient and caregiver registry. (1) The office shall create and maintain a registry that includes all patients and caregivers authorized to possess medical cannabis products pursuant to this chapter. The registry shall be an electronic system accessible online by authorized users. The office shall add an individual as a patient to the registry, and issue the individual a registry identification card and unique identification code, if the individual submits all of the following:

AB1040,,189 (a) The individual’s name, address, and contact information.

AB1040,,190 (b) Proof that the individual is a resident.

AB1040,,191 (c) Proof that the individual is at least 18 years of age or, if the individual is under the age of 18, written consent from all parents or, if legal custody of the individual has been awarded by a court, from all persons awarded legal custody of the individual to be included in the patient and caregiver registry.

AB1040,,192 (d) If the individual has previously been convicted of a crime, proof that the individual is not on parole, probation, or extended supervision.

AB1040,,193 (e) A written confirmation from a prescriber that the prescriber has established a bona fide relationship with the individual, met with the individual in person, reviewed the individual’s health care records, performed any tests to identify the presence of a medical condition to a reasonable degree of medical certainty, and determined that the individual has at least one of the following medical conditions:

AB1040,,194 1. Cancer.

AB1040,,195 2. HIV or AIDS.

AB1040,,196 3. Seizures and epilepsy.

AB1040,,197 4. Post-traumatic stress disorder.

AB1040,,198 5. Alzheimer’s disease.

AB1040,,199 6. Glaucoma.

AB1040,,200 7. Severe chronic pain.

AB1040,,201 8. Severe chronic nausea.

AB1040,,202 9. Severe muscle spasms.

AB1040,,203 10. Parkinson’s disease.

AB1040,,204 11. Multiple sclerosis.

AB1040,,205 12. Amyotrophic lateral sclerosis.

AB1040,,206 13. Chronic motor or vocal tic disorder.

AB1040,,207 14. Tourette syndrome.

AB1040,,208 15. Inflammatory bowel disease.

AB1040,,209 16. Any terminal illness with a probable life expectancy of less than one year.

AB1040,,210 (2) (a) Written confirmation from a prescriber under par. (b) or sub. (1) (e) is valid for 2 years from the day that the prescriber determines the patient has or continues to have at least one of the conditions described under sub. (1) (e).

AB1040,,211 (b) No earlier than 90 days prior to the expiration of the written confirmation from a prescriber under this paragraph or sub. (1) (e), a patient may obtain and submit written confirmation from a prescriber consistent with sub. (1) (e) that the patient continues to have at least one of the conditions described under sub. (1) (e).

AB1040,,212 (3) At the time a patient applies to the office for inclusion on the patient and caregiver registry under this section and annually thereafter, a patient shall pay a fee of $100 or, if the patient qualifies for a hardship exception as determined by the office, a fee of $50.

AB1040,,213 (4) If a patient is added to the registry under sub. (1) or submits written confirmation that the patient continues to have at least one of the conditions described under sub. (1) (e) consistent with sub. (2), the office shall record on the registry the prescriber who determined that the patient has or continues to have at least one of the conditions described under sub. (1) (e) and the condition under sub. (1) (e) that qualifies the patient for inclusion on the patient and caregiver registry.

AB1040,,214 (5) If an individual under the age of 18 is added to the registry and legal custody of the individual has been awarded by a court, all person’s awarded legal custody of the individual shall inform any noncustodial parent of the individual that the individual is included on the registry.

AB1040,,215 (6) (a) A patient included in the patient and caregiver registry under this section may designate up to 3 caregivers who may purchase and possess medical cannabis products on the patient’s behalf, except as provided in par. (b). A caregiver designated by a patient shall be included in the patient and caregiver registry under this section and shall be issued a registry identification card that evidences their inclusion as a caregiver in the registry.

AB1040,,216 (b) If a patient is under the age of 18, the office shall designate the patient’s parents or guardians as the patient’s caregivers. The minor patient’s parents or guardians may designate one additional caregiver who may purchase and possess medical cannabis products on the minor patient’s behalf.

AB1040,,217 (c) No individual may act as a caregiver under this subsection unless the individual is 21 years of age or older, is a resident, and has not been convicted of a crime, unless at least 10 years have passed since the completion of any sentence imposed for the crime, including any period of incarceration, parole, or extended supervision, and any period of probation imposed for the crime.

AB1040,,218 (d) No individual may act as a caregiver under this section for more than 5 patients, except as provided in par. (e).